Company intelligence
Biofabri
BIOFABRI is a biotech company focused on vaccines for Human health
About Biofabri
Biofabri is a Spanish biopharmaceutical company founded in 2008 based on a legacy of more than 70 years' experience in the pharmaceutical industry. Its main activity focuses on the research&development and industrial production of vaccines for human use and the contract manufacturing and distribution (CDMO) of pharmaceutical products. Our most advanced project is a vaccine against Tuberculosis (at phase Ib), that is being developed in collaboration with the University of Zaragoza, Pasteur Institute and TB Vaccine Initiative. We count with a valuable infrastructure and knowledge to address biotech projects from a laboratory stage to a large scale production. Biofabri is a company of Zendal group, a bioparmecutical group focsed on vaccines and biotechnology.
Verified activity
Signals from Biofabri
5 published signals
Research & Knowledge
Biofabri completed the Phase 3 clinical trial evaluating MTBVAC in newborns across South Africa, Senegal, and Madagascar, with participants continuing into follow-up to assess safety and efficacy.
Reported by Biofabri
Research & Knowledge
Biofabri participated in the Phase 3 trial of the MTBVAC vaccine candidate, MTBVACN3, fully enrolled in newborns.
Reported by Rolando Pajon, PhD
Research & Knowledge
Biofabri announced two fully enrolled clinical trials for the generation of efficacy readouts: the IAVI-sponsored IMAGINE Phase 2b trial in adults and adolescents, and the MTBVACN3 Phase 3 trial in neonates.
Reported by Rolando Pajon, PhD
Partnerships
Biofabri achieved a milestone in the Phase 3 development of MTBVAC, supported by the TuBerculosis Vaccine Initiative, the European & Developing Countries Clinical Trials Partnership, the European Commission, and the European Health and Digital Executive Agency.
Reported by Rolando Pajon, PhD
People
Biofabri is hiring a Regulatory Affairs Specialist for Human Health international challenge in the biotechnology and human health sector.
Reported by Biofabri